Life Science Marketing Agency

Picture the kickoff: four scientists at the table, explaining a mechanism. To ask the right questions, we need to already understand how a therapy moves from discovery into the pipeline, through phase 1 and 2 — and we do.

Around fifteen biotech and life science clients over twenty years taught us the vocabulary and, more importantly, when to use it.

The hardest question in this sector isn’t explaining the science — it’s articulating why yours matters when adjacent companies sound alike. That’s usually where the kickoff earns itself.

Brilliant founders, professors, researchers: experts in their field, rarely storytellers. That’s not a flaw. It’s why we exist.

The investor scans, the scientist verifies, the HCP checks the evidence. We structure story and site so each finds their layer — without flattening the science that earned your credibility.

Precision that legal and scientific review can approve, in language a first-time reader can follow.

Ninety per cent of our clients continue after the first project — some relationships run past ten years. In a sector where the story changes per phase, that continuity pays: we already know the pipeline when the next milestone lands.

A life science marketing agency helps organisations in biopharma, diagnostics, research tools and adjacent fields get understood by the audiences that matter: scientists, clinicians, investors, partners and procurement. The work spans strategy, branding, websites, content and findability.

The defining requirement: the science stays intact. Marketing that flattens the substance disqualifies itself with exactly the readers it was meant to convince.

The reader. In life sciences, every audience verifies: claims get checked against evidence, language gets checked against the datasheet, and anything that oversells costs trust that took years to build.

That changes the playbook: longer cycles, more stakeholders, regulatory lines around what can be said — and a premium on precision that generic B2B marketing treats as optional.

Yes — biotech is one of our deepest sectors, and it has its own dedicated page. As a biotech marketing agency we cover the full route from discovery-stage story to clinical-stage credibility.

The short version of the split: this page covers marketing as a discipline for the broader life sciences field; the biotech page covers everything we do for that sector specifically.

Four decisions: which audiences matter this phase, what each needs to believe, which channels reach them, and how you’ll measure whether it worked. Everything else — content, campaigns, design — follows from those four.

A good strategy fits on a few pages. Without those pages, the marketing becomes a collection of loose actions no one can add up.

Yes — it’s part of the field. We know where the lines run per phase and per market, and we write precisely enough that legal review gets easier rather than harder.

Constraint isn’t the enemy of a strong story. Vagueness is.

Yes — and deliberately in one hand. In life sciences the website is where every journey lands: read before the meeting, forwarded to the committee, checked during diligence.

The same team that builds the strategy designs and builds the site, so nothing gets lost between the thinking and the thing.

The digital layer where most journeys now start: findable pages, content matched to real search behaviour, campaigns that reach the right desks, and measurement that shows what worked.

Increasingly it includes AI findability too — your customers ask ChatGPT and Perplexity before they ask you, and we structure content so those systems can read and cite it correctly.

That depends on scope, stage and the depth of the content work. Early in the conversation we share an estimate per phase, so you see what each part costs before it begins.

Worth noting: search intent in this field is among the most expensive to buy — every position won organically displaces advertising spend at the top of the market.

Yes — a substantial part of our client base is in the US and the UK, alongside Europe. We work from Amsterdam through shared Slack and biweekly calls, in a process built for time zones years ago.

In practice, US clients rarely see us in person. The work doesn’t suffer for it; picking up your field quickly matters far more than sharing a postcode.

A brand identity typically runs six to ten weeks; a full brand-plus-website project ten to sixteen; ongoing marketing engagements are scoped per quarter. Timelines are planned per phase upfront — with internal decision-making planned in from day one, because that’s where projects in this field usually slow down.

Three things.

One: twenty years and more than three hundred websites and brands, a substantial share of them in knowledge-intensive fields like this one. We pick up your science fast, and we know which communication survives a critical reader and which doesn’t.

Two: strategy, brand, website and content in one team. No handovers where the substance gets lost in translation.

Three: we build for findability in both worlds — search engines and AI answers — and we measure what actually happens.

Volume isn’t our position. Depth is.